ATM and head and neck cancer: However, in models where ATM is lost or not functional we observe the opposite effect, as demonstrated by the 32–79% reduction in phosphorylation of RAD50 in the ATM KO FaDu head-and-neck cancer xenograft model treated with AZD6738 for 24 h (Fig. 6a, b).